[go: up one dir, main page]

UY36662A - BENZOXABOROL COMPOUNDS AND USE OF THE SAME - Google Patents

BENZOXABOROL COMPOUNDS AND USE OF THE SAME

Info

Publication number
UY36662A
UY36662A UY0001036662A UY36662A UY36662A UY 36662 A UY36662 A UY 36662A UY 0001036662 A UY0001036662 A UY 0001036662A UY 36662 A UY36662 A UY 36662A UY 36662 A UY36662 A UY 36662A
Authority
UY
Uruguay
Prior art keywords
compounds
same
ch2ch2ch3
ch2ch3
benzoxaborol compounds
Prior art date
Application number
UY0001036662A
Other languages
Spanish (es)
Inventor
Alemparte-Gallardo Carlos
R K M (Dickon) Alley
S Hernandez Vincent
J Plattner Jacob
Barros-Aguirre David
Ilaria Giordano
Xianfeng Li
Original Assignee
Anacor Pharmaceuticals Inc
Glaxosmithkline Intellectual Property (No 2) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc, Glaxosmithkline Intellectual Property (No 2) Ltd filed Critical Anacor Pharmaceuticals Inc
Priority to UY0001036662A priority Critical patent/UY36662A/en
Publication of UY36662A publication Critical patent/UY36662A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan benzoxaboroles sustituidos cuya estructura comprende la fórmula III: en donde R3 se selecciona a partir de –CH3, –CH2CH3, –CH2=CH2, –CH2CH2CH3, –CH(CH3)2, –CH2CH2=CH2 y ciclopropilo, R1 y R2 se seleccionan cada uno independientemente a partir de H, -CH3, -CH2CH3, –CH2CH2CH3 y –CH(CH3)2; composiciones que contienen estos compuestos, su uso en terapia, incluyendo su uso como agentes anti-micobacterianos, por ejemplo, en el tratamiento de una infección micobacteriana en un mamífero, y los métodos para la preparación de estos compuestos.Substituted benzoxaboroles are provided whose structure comprises formula III: wherein R3 is selected from –CH3, –CH2CH3, –CH2 = CH2, –CH2CH2CH3, –CH (CH3) 2, –CH2CH2 = CH2 and cyclopropyl, R1 and R2 each is independently selected from H, -CH3, -CH2CH3, –CH2CH2CH3 and –CH (CH3) 2; Compositions containing these compounds, their use in therapy, including their use as anti-mycobacterial agents, for example, in the treatment of a mycobacterial infection in a mammal, and methods for the preparation of these compounds.

UY0001036662A 2016-04-29 2016-04-29 BENZOXABOROL COMPOUNDS AND USE OF THE SAME UY36662A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY0001036662A UY36662A (en) 2016-04-29 2016-04-29 BENZOXABOROL COMPOUNDS AND USE OF THE SAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY0001036662A UY36662A (en) 2016-04-29 2016-04-29 BENZOXABOROL COMPOUNDS AND USE OF THE SAME

Publications (1)

Publication Number Publication Date
UY36662A true UY36662A (en) 2017-11-30

Family

ID=60892317

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036662A UY36662A (en) 2016-04-29 2016-04-29 BENZOXABOROL COMPOUNDS AND USE OF THE SAME

Country Status (1)

Country Link
UY (1) UY36662A (en)
  • 2016

Similar Documents

Publication Publication Date Title
CO2017008809A2 (en) Benzoxaborol compounds and their use
CR20160064A (en) TRICYCLIC BENZOXABOROL COMPOUNDS AND USES OF THE SAME
UY38076A (en) TETRAHYDROQUINAZOLINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
UY38070A (en) SUBSTITUTE QUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
PE20211775A1 (en) BENZOXACEPINE OXAZOLIDINONE COMPOUNDS AND METHODS OF USE
PE20181093A1 (en) HETEROCYCLIC COMPOUNDS AND USES OF THEM
AR089671A1 (en) 1,4-DIHIDROPIRIMIDINAS 4,4-DISUSTITUIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
CR20180578A (en) USEFUL REPLACED CARBONUCLEOSIDE DERIVATIVES AS ANTHINEOPLASTIC AGENTS
CL2013002690A1 (en) Compounds derived from bis (fluoroalkyl) -1,4-benzodiazepinone, notch inhibitors; crystalline compound; pharmaceutical composition that includes them; pharmaceutical combination; and its use for the treatment of cancer.
PA8799101A1 (en) TIENOPIRIMIDINE AND PIRAZOLOPIRIMIDINE COMPOUNDS AND THEIR USE AS INHIBITORS OF MTIN QUINASE AND KINASE P13
PE20191496A1 (en) 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES
AR048813A1 (en) 5,6-DIALQUIL-7-AMINO-TRIAZOLOPIRIMIDINAS, PROCEDURES FOR THEIR PREPARATION AND THE USE OF THEM TO COMBAT HARMFUL FUNGI
PE20211782A1 (en) COMPOSITIONS OF 5-CHLORO-2-DIFLUOROMETOXIFENIL PYRAZOLOPYRIMIDINE, COMPOSITIONS AND METHODS OF USE OF THE SAME
UY35293A (en) ISOTIAZOLES REPLACED WITH AMINO
AR111494A1 (en) ANILINOQUINAZOLINE C₅ COMPOUNDS AND ITS USE IN CANCER TREATMENT
CR20220116A (en) HETEROCYCLIC COMPOUNDS
AR116906A1 (en) DERIVATIVES OF BICYCLIC HETEROARYL
CL2023003921A1 (en) Transglutaminase inhibitors
AR107937A1 (en) CINOLIN-4-AMINA COMPOUNDS AND ITS USE IN CANCER TREATMENT
AR117251A1 (en) MACROCYCLIC COMPOUND AS ACTIVATOR OF NRF2
PE20201148A1 (en) 5,6-FUSED BICYCLE COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
UY36662A (en) BENZOXABOROL COMPOUNDS AND USE OF THE SAME
ECSP24007534A (en) TRANSGLUTAMINASE INHIBITORS
CL2023003979A1 (en) Transglutaminase inhibitors
CO2022006942A2 (en) 1,8-naphthyridin-2-one compounds for the treatment of an autoimmune disease

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20230711